To The Moon

Intel Options Explode and $25 Calls Surge Amid Possible US Stake in Company Fueled by reports of Trump administration talks to take stake in, $Intel(INTC)$   shares surged 23% last week. Options volume hit a 6-month high, with aggressive call buying dominating sentiment. Options Data Analysis Volatility & Sentiment Signals: ~Implied Volatility (IV): 60.13%, Sitting at 64th percentile of 1-year range. ~Put Skew: Plunged from +6 in April to -7.9, signaling reduced demand for downside protection. Open Interest: The Put/Call ratio stands at 0.59, indicating a dominance of call options. Notably, open interest is heavily concentrated in the $25 strike call options expiring on September 19, 2025. Max Open Interest

TSMC Arizona Posts First Positive Equity-Method Contribution: What's Driving It and What Could Derail It What happened $Taiwan Semiconductor Manufacturing(TSM)$  quietly crossed a milestone in Q2: its Arizona subsidiary showed a positive 'share of profits of investee' in the company's consolidated filing. By contrast, JASM (Kumamoto) remained in the red, underscoring a faster profitability turn in the U.S. asset than in Japan at this stage of ramp. By the numbers ~Node mix: In Q2, 5-nanometer technologies contributed 36% of wafer revenue; N4/N4P/N4X are classified by TSMC as part of the 5-nanometer family, so Arizona's N4 output is inside that bucket. ~Arizona status: U.S. Commerce said 4-nm production in Phoenix

$Dover(DOV)$ I added to my position in Dover (DOV) following its solid Q2 2025 results, where adjusted EPS of $2.44 beat expectations and revenue grew 5% to $2.05 billion. While much of the top-line gain came from acquisitions and currency, margin improvements and strong cash flow highlight operational efficiency. Importantly, management raised full-year adjusted EPS guidance to $9.35–$9.55, signaling confidence despite macro uncertainties. With a diversified industrial portfolio and disciplined execution, Dover continues to demonstrate resilience, making it a compelling addition to my holdings at this stage.

$Apple(AAPL)$ I added to my Apple (AAPL) position following Morgan Stanley’s bullish iPhone forecast upgrade, now expecting 54M units in the September quarter versus 50M previously. The revision reflects pent-up replacement demand, stronger designs, and margin improvements. Importantly, peak tariff concerns have eased while regulatory impacts remain softer than feared. With services pricing yet to be adjusted in two years, Apple holds untapped growth potential. Valuation relative to the S&P 500 remains fair, and upward estimate revisions historically drive multiple expansion, strengthening my conviction in Apple’s sustained growth trajectory.

$SMMT 20250822 25.0 PUT$ 我看好賣出SMMT $25認沽期權的策略，即便被行權接貨，安全邊際依然極高。從基本面看，SMMT專注於開發ivonescimab（雙特異性抗體），在非小細胞肺癌（NSCLC）治療中展現競爭力。2025年Q1財報顯示，現金及短期投資達3.613億美元，無重大長期債務，財務穩健（流動資產為短期負債的2.13倍）。儘管Q1淨虧損6290萬美元（每股-0.09美元），但其臨床進展亮眼：HARMONi-6試驗顯示ivonescimab聯合化療在NSCLC中進展自由存活期（PFS）顯著優於對照組，獲中國NMPA批准，潛在峰值年收入達100億美元。產品競爭力獲市場認可，與阿斯利康洽談150億美元授權交易進一步提升估值空間。 從估值角度，SMMT當前股價26.29美元（截至2025年8月18日），市淨率（P/B）約為高位，但DCF模型估計內在價值遠超當前價格（WallStreetZen估計合理價值僅0.18美元，但分析師平均目標價34.73美元，潛在上漲64.6%）。技術分析顯示，$25為一年內關鍵支撐位（52周低點2.10美元，高點36.91美元），近期RSI（57.33）處中性，CCI（11.65）未超買，短期波動後反彈概率高。行業趨勢方面，生物科技與免疫療法市場2025-2030年預計CAGR超10%，SMMT的全球試驗與合作強化其領先地位。 即便期權被行權，$25的接貨價遠低於分析師目標價（最高44美元），結合穩健現金流與臨床催化劑，風險可控，長期獲利空間廣闊。此策略兼具防守性（低估值支撐）與進攻性（臨床與合作催化），安全邊際顯著。

$FIG 20250829 65.0 PUT$ Figma財務表現亮眼，2024財年（截至2025年1月）營收7.49億美元，同比增長48%，LTM營收超8.2億美元。2025財年Q1實現4490萬美元淨利，展現“增長+盈利”雙贏。账面現金超15億美元，幾無長期債務，包括Adobe支付的10億美元解約金，為AI投資與平台建設提供資金支持。Figma開創雲端SaaS+實時協作模式，解決傳統設計軟件痛點，採用“增值免費”策略，吸引1300萬註冊用戶，2024財年毛利率達91%。其插件與模板生態增強用戶粘性。儘管AI浪潮帶來依賴第三方模型、數據合規及同質化競爭風險，Figma積極布局AI，長期成長潛力巨大。當前股價下跌或為短期波動，未來前景依然樂觀。我沽出認沽期權做好。

$MSTR STRADDLE 250919 CALL 320.0/PUT 320.0$ share for coins 

🌌🚀🎭 From Theta Decay to Kopi Breaks: My Tribute to my special SG 🇸🇬 Sis Space Rocket 🎭🚀🌌 🌟🌟🌟🚀 Sis, your Star Contributor feature wasn’t just a profile; it was like reading the transcript of a perfectly executed straddle: balanced, bold, and paying off on both sides. I’m so grateful for the shout-out, but even more grateful for the hours you poured into me through personal emails and late-night messages when I was learning options. While others would’ve said “aiya, too suay, give up lah,” you broke down Greeks patiently, rolled me through strategies like a pro, and kept me laughing when volatility made me want to margin-call myself. That kind of generosity is rarer than finding vega in a value stock. Your journey shines with resilience! 🤩 Losing USD $22K on SEV would’ve grounded most trader

Both $POP MART(09992)$ and $XIAOMI-W(01810)$ have impressive growth prospects! Popmart's globalization strategy is paying off, with overseas revenue expected to surpass domestic revenue. Xiaomi's diversified business segments, including smartphones and EVs, are driving strong revenue growth. Personally, I think Xiaomi's stable growth trajectory makes it a more reliable choice, but Popmart's potential for explosive growth can't be ignored 🤔💸

$UnitedHealth(UNH)$ Seize the Moment: Why UnitedHealth (UNH) at $300 is a Golden Ticket to Wealth in 2025 In the grand theater of Wall Street, where fortunes are made and lost with the flick of a ticker, a new star has emerged on the horizon—UnitedHealth Group (UNH). As of August 19, 2025, whispers of a “last call to buy at $300” are electrifying the X posts, and for good reason. Warren Buffett’s Berkshire Hathaway, the Oracle of Omaha himself, has thrown his weight behind UNH, snagging 5.039 million shares at an average of $314 per share in Q2 2025, a stake now valued at $1.57 billion. This isn’t just a stock pick; it’s a masterstroke, a beacon for savvy investors to ride the wave of a healthcare giant poised for a glorious ascent. Let’s dive into

Bitcoin at $115K: The Cosmic Dip That Could Ignite a Galactic Bull Run As the digital cosmos trembles, Bitcoin has plummeted to $115,000, a dramatic swoon from its dazzling new all-time high near $125,000 last week—its fourth celestial ascent of 2025. With $570 million in liquidations unleashed by profit-taking zealots in the past 24 hours, the crypto galaxy is buzzing with a primal question: Is this a healthy dip to buy, or the prelude to a bull run’s spectacular crash? As of 11:17 AM NZST on August 19, 2025, I’m here to argue a bold, electrifying thesis: this dip is not just a buying opportunity—it’s the gravitational pull igniting a galactic bull run, propelled by a cosmic convergence of quantum adoption, macro defiance, and human greed. Buckle up, stargazers, for a journey beyond the c

I was excited to see the recent news about Berkshire Hathaway $Berkshire Hathaway(BRK.A)$  , led by Warren Buffett, releasing its 13F filing for the second quarter of 2025 today. The highlight for me was that Berkshire initiated a new position in U.S. health insurance giant UnitedHealth$UnitedHealth(UNH)$  , purchasing 5.039 million shares for about $1.6 billion. The average purchase price was $314 per share, and by the end of the quarter, the position was valued at $1.57 billion, making it the 18th largest holding in Berkshire's portfolio—just behind Amazon and $Constellation(STZ)$  . This move by Buffett, a legendary

Overall Market Overview Global markets ended the week with muted movements as investors awaited pivotal events, including US retail earnings and Fed Chair Jerome Powell’s speech at the Jackson Hole summit. While US equities were nearly flat, Europe delivered a mixed performance, and Asia generally closed higher on optimism surrounding geopolitical discussions. US: Investors in Wait-and-See Mode US stocks ended largely unchanged, with the Dow Jones $DJIA(.DJI)$  slipping 34.30 points to 44,911.82 and the S&P 500 $S&P 500(.SPX)$  easing 0.65 points to 6,449.15. Investors held back major moves ahead of retail earnings reports and

I have been closely watching the recent movement in Bitcoin, and I find the drop to $115,000 after touching a new all-time high last week, near $125,000, quite interesting. This marks its fourth significant peak this year, and the subsequent pullback feels like a natural part of the cycle. The fact that investors' profit-taking triggered more than $570 million in liquidations over the past 24 hours does not surprise me; it seems like a healthy correction after such a strong run. I believe this is indeed a very healthy pullback before another rally. The market often needs these dips to shake out over-leveraged positions and reset sentiment, and the current level around $115,000 looks like a solid buying opportunity. Having seen Bitcoin recover from dips in the past, I am optimistic that thi